Bio-Rad Laboratories, Inc. (NYSE:BIO.B - Get Free Report)'s share price hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as $225.29 and last traded at $225.29, with a volume of 120 shares changing hands. The stock had previously closed at $241.99.
Bio-Rad Laboratories Stock Performance
The company has a quick ratio of 4.85, a current ratio of 6.48 and a debt-to-equity ratio of 0.18. The company has a 50-day moving average price of $279.01 and a two-hundred day moving average price of $316.47. The company has a market capitalization of $6.31 billion, a PE ratio of -3.46 and a beta of 0.94.
Bio-Rad Laboratories (NYSE:BIO.B - Get Free Report) last issued its quarterly earnings results on Thursday, February 13th. The company reported $2.90 EPS for the quarter. Bio-Rad Laboratories had a negative net margin of 71.86% and a positive return on equity of 3.90%.
Bio-Rad Laboratories Company Profile
(
Get Free Report)
Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.
Featured Stories
Before you consider Bio-Rad Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bio-Rad Laboratories wasn't on the list.
While Bio-Rad Laboratories currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
